Business Context and Reporting Period
Company: Medifast, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2008
Business Overview: Medifast operates in the weight management industry through two primary segments: the "Medifast" segment (Direct, Take Shape for Life, and Doctors) and the "All Other" segment (Hi-Energy and Medifast Weight Control Centers). The company reported strong growth driven by its Take Shape for Life division and the expansion of its brick-and-mortar clinic network.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2008 |
Nine Months Ended Sep 30, 2008 |
Nine Months Ended Sep 30, 2007 |
|---|---|---|---|
| Revenue | $27,281,000 | $79,987,000 | $63,975,000 |
| Gross Profit | $20,759,000 | $60,688,000 | $48,031,000 |
| Gross Margin | 76.1% | 75.9% | 75.1% |
| Net Income | $1,549,000 | $4,486,000 | $3,235,000 |
| Diluted EPS | $0.11 | $0.32 | $0.24 |
| Cash and Equivalents | $2,091,000 | Balance Sheet (Sep 30, 2008) | |
| Total Debt (Current + Long-term) | $7,765,000 (Line of Credit: $3.13M; Long-term: $4.38M) | ||
| Operating Cash Flow (9mo) | $4,409,000 |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 25% year-over-year for the nine months ended September 30, 2008 ($80.0M vs. $64.0M). The Take Shape for Life division grew 77% and Weight Control Centers grew 66%, offsetting a 2% decline in the direct marketing channel.
- Profitability: Net income rose 41% to $4.5 million for the nine-month period. Gross margins improved to 75.9% from 75.1% due to operational efficiencies, new shipping rules, and a price increase implemented on July 1, 2008.
- Expense Management: Selling, general, and administrative (SG&A) expenses increased by $10.7 million, primarily driven by a $7.3 million increase in variable commissions for the Take Shape for Life division. However, advertising spend decreased by $400,000 despite revenue growth, indicating improved efficiency.
- Balance Sheet: Inventory increased by $2.57 million to $11.76 million. The line of credit increased by $1.53 million to $3.13 million to support operations and expansion.
Outlook, Risks, and Unusual Items
- Guidance: Management anticipates an effective tax rate of approximately 32-34% for the full year 2008. No specific revenue or earnings guidance was provided for the remainder of the year.
- Expansion Plans: The company plans to open two additional corporately owned clinics in Houston by the end of 2008 and has sold franchise rights for clinics in Baltimore and California.
- Unusual Items / Contingencies:
- Litigation Settlement: A settlement was reached regarding a lawsuit filed by Leonard Z. Sotomeyer. Medifast agreed to pay $130,000 in cash and issue treasury stock valued at $70,000. This will result in a one-time charge of approximately $200,000 to earnings in the fourth quarter of 2008.
- Stock Compensation: In July 2008, the Board approved restricted stock grants to executives and board members, resulting in increased stock compensation expense.
- Risks: The company notes that inflation is negatively impacting raw material costs. Additionally, the "All Other" segment (clinics and Hi-Energy) continues to operate at a loss, though the loss narrowed year-over-year.
Investor Verification Checklist
- Take Shape for Life Sustainability: Verify if the 77% growth in the Take Shape for Life division is sustainable given the heavy reliance on variable commission expenses.
- Clinic Economics: Assess the profitability timeline for the newly opened Weight Control Centers, as the "All Other" segment remains unprofitable despite revenue growth.
- Inventory Levels: Review the $2.6 million increase in inventory to ensure it aligns with sales velocity and does not indicate obsolescence risk.
- Debt Utilization: Monitor the utilization of the line of credit, which increased significantly to $3.13 million, and its impact on liquidity.
- Q4 Charge Impact: Confirm the exact timing and accounting treatment of the $200,000 litigation settlement charge in the fourth quarter.